Of the four FDA-approved drugs for AD treatment, three are acetylcholinesterase inhibitors (AChEIs) (donepezil, galantamine, rivastigmine) (2) and one, memantine (3), is an N-methyl-D-aspartate (NMDA) receptor antagonist. The gene discussed is ACHE; the disease is Alzheimer disease.